Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20


First case report of M1 macrophage polarization in an untreated symptomatic patient with toxoplasmosis.

De Luca G, Di Lisio C, Lattanzio G, D'Antuono T, Liberatore M, Aiello FB.

BMC Infect Dis. 2018 Mar 27;18(1):139. doi: 10.1186/s12879-018-3048-2.


Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors.

Marchetti A, Barberis M, Franco R, De Luca G, Pace MV, Staibano S, Volante M, Buttitta F, Guerini-Rocco E, Righi L, D'antuono T, Scagliotti GV, Pinto C, De Rosa G, Papotti M.

J Thorac Oncol. 2017 Nov;12(11):1654-1663. doi: 10.1016/j.jtho.2017.07.031. Epub 2017 Aug 14.


Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays.

Marchetti A, Pace MV, Di Lorito A, Canarecci S, Felicioni L, D'Antuono T, Liberatore M, Filice G, Guetti L, Mucilli F, Buttitta F.

Lung Cancer. 2016 Sep;99:11-6. doi: 10.1016/j.lungcan.2016.06.005. Epub 2016 Jun 14.


ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.

Marchetti A, Di Lorito A, Pace MV, Iezzi M, Felicioni L, D'Antuono T, Filice G, Guetti L, Mucilli F, Buttitta F.

J Thorac Oncol. 2016 Apr;11(4):487-95. doi: 10.1016/j.jtho.2015.12.111. Epub 2016 Feb 22.


Chromogenic in situ hybridization and p16/Ki67 dual staining on formalin-fixed paraffin-embedded cervical specimens: correlation with HPV-DNA test, E6/E7 mRNA test, and potential clinical applications.

Zappacosta R, Colasante A, Viola P, D'Antuono T, Lattanzio G, Capanna S, Gatta DM, Rosini S.

Biomed Res Int. 2013;2013:453606. doi: 10.1155/2013/453606. Epub 2013 Nov 24.


Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing.

Buttitta F, Felicioni L, Del Grammastro M, Filice G, Di Lorito A, Malatesta S, Viola P, Centi I, D'Antuono T, Zappacosta R, Rosini S, Cuccurullo F, Marchetti A.

Clin Cancer Res. 2013 Feb 1;19(3):691-8. doi: 10.1158/1078-0432.CCR-12-1958. Epub 2012 Dec 14.


Detection of nuclear and membrane antigens by liquid-based cytology following long-term storage of d1 cells, karpas cells, and peripheral blood mononuclear cells.

Zappacosta R, Aiello FB, D'Antuono T, Procopio AD, Durum SK, Conti P, Rosini S.

Ann Clin Lab Sci. 2011 Fall;41(4):353-9.


The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance.

Di Carlo E, D'Antuono T, Pompa P, Giuliani R, Rosini S, Stuppia L, Musiani P, Sorrentino C.

Clin Cancer Res. 2009 May 1;15(9):2979-87. doi: 10.1158/1078-0432.CCR-08-1951. Epub 2009 Apr 14.


Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung.

Marchetti A, Felicioni L, Pelosi G, Del Grammastro M, Fumagalli C, Sciarrotta M, Malatesta S, Chella A, Barassi F, Mucilli F, Camplese P, D'Antuono T, Sacco R, Buttitta F.

Hum Mutat. 2008 May;29(5):609-16. doi: 10.1002/humu.20707.


The prostate-associated lymphoid tissue (PALT) is linked to the expression of homing chemokines CXCL13 and CCL21.

Di Carlo E, Magnasco S, D'Antuono T, Tenaglia R, Sorrentino C.

Prostate. 2007 Jul 1;67(10):1070-80.


Endogenous IL-12 triggers an antiangiogenic program in melanoma cells.

Airoldi I, Di Carlo E, Cocco C, Taverniti G, D'Antuono T, Ognio E, Watanabe M, Ribatti D, Pistoia V.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3996-4001. Epub 2007 Feb 23.


Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections.

Di Carlo E, D'Antuono T, Contento S, Di Nicola M, Ballone E, Sorrentino C.

Am J Transplant. 2007 Jan;7(1):201-10. Epub 2006 Oct 25.


Endomyocardial infiltration by B and NK cells foreshadows the recurrence of cardiac allograft rejection.

Sorrentino C, Scarinci A, D'Antuono T, Piccirilli M, Di Nicola M, Pasquale M, Di Iorio C, Di Carlo E.

J Pathol. 2006 Jul;209(3):400-10.


[Studies of molecular morphology with immunohistochemistry in breast ductal proliferations].

Angelucci D, Castrilli G, Di Giovannantonio L, D'antuono T, Pelliciotta A, Bellocci R.

Pathologica. 2005 Aug;97(4):167-8. Italian. No abstract available.


Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy.

Airoldi I, Di Carlo E, Cocco C, Sorrentino C, Fais F, Cilli M, D'Antuono T, Colombo MP, Pistoia V.

Blood. 2005 Dec 1;106(12):3846-53. Epub 2005 Aug 4. Erratum in: Blood. 2006 Jan 1;107(1):45. Colombo, Mario Paulo [corrected to Colombo, Mario Paolo].


Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells.

Galiè M, Sorrentino C, Montani M, Micossi L, Di Carlo E, D'Antuono T, Calderan L, Marzola P, Benati D, Merigo F, Orlando F, Smorlesi A, Marchini C, Amici A, Sbarbati A.

Carcinogenesis. 2005 Nov;26(11):1868-78. Epub 2005 Jun 23.


Int6 expression can predict survival in early-stage non-small cell lung cancer patients.

Buttitta F, Martella C, Barassi F, Felicioni L, Salvatore S, Rosini S, D'Antuono T, Chella A, Mucilli F, Sacco R, Mezzetti A, Cuccurullo F, Callahan R, Marchetti A.

Clin Cancer Res. 2005 May 1;11(9):3198-204.


Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway.

Di Carlo E, Cappello P, Sorrentino C, D'Antuono T, Pellicciotta A, Giovarelli M, Forni G, Musiani P, Triebel F.

J Pathol. 2005 Jan;205(1):82-91.


Low-dose interferon-gamma-producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity.

Airoldi I, Meazza R, Croce M, Di Carlo E, Piazza T, Cocco C, D'Antuono T, Pistoia V, Ferrini S, Corrias MV.

Br J Cancer. 2004 Jun 1;90(11):2210-8.


Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression.

Diodoro MG, Di Carlo E, Zappacosta R, Iezzi M, Coletti A, Modesti A, D'Antuono T, Forni G, Musiani P.

Int J Cancer. 2000 Nov 1;88(3):329-35.

Supplemental Content

Loading ...
Support Center